<DOC>
	<DOC>NCT02088697</DOC>
	<brief_summary>The purpose of this study is to investigate the bioequivalence of ASC-01 Placebo and sertraline Tablet in Japanese healthy male subjects.</brief_summary>
	<brief_title>A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Sertraline</mesh_term>
	<criteria>Healthy male volunteers aged 20 to 40 years. Have a body mass index (BMI) between 18.5 and 25.0 kg/m2 and a weight of at least 50 kg. History of any clinically important disease or disorder which, in the opinion of the Investigator, may either put the volunteer at risk because of participation in the study. History or presence of gastrointestinal, hepatic, or renal disease or any other condition known to interfere with absorption, distribution, metabolism, or excretion of drugs. Any clinically significant abnormalities in the physical examination, clinical laboratory values, 12lead ECG, or vital signs, as judged by the Investigator.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>